Anti-TPPP antibody produced in rabbit
SIGMA/HPA036576 - Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Synonym: Anti-TPPP/p25; Anti-TPPP1; Anti-p25; Anti-p25alpha
Product Type: Chemical
Enhanced Validation-Orthogonal RNAseq Confirmation Immunohistochemistry analysis in human cerebral cortex and liver tissues using HPA036576 antibody. Corresponding TPPP RNA-seq data are presented for the same tissues.
Enhanced Validation-By Independent Antibodies Immunohistochemical staining of human cerebral cortex, liver, lower gastrointestinal and pancreas using Anti-TPPP antibody HPA036576 (A) shows similar protein distribution across tissues to independent antibody HPA036575 (B).
Immunohistochemistry Immunohistochemical staining of human cerebral cortex shows strong cytoplasmic and nuclear positivity in glial cells.
Immunohistochemistry Immunohistochemical staining of human lower gastrointestinal shows weak cytoplasmic positivity in peripheral ganglion.
Immunohistochemistry Immunohistochemical staining of human pancreas shows moderate cytoplasmic positivity in islets of Langerhans.
Immunohistochemistry Immunohistochemical staining of human liver shows no positivity in hepatocytes as expected.
Immunofluorescence Immunofluorescent staining of human cell line A549 shows localization to cytosol & mitochondria.
Western Blotting Western blot analysis in human cerebral cortex tissue.
| antibody form | affinity isolated antibody |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| conjugate | unconjugated |
| enhanced validation | orthogonal RNAseq independent Learn more about Antibody Enhanced Validation  |
| form | buffered aqueous glycerol solution |
| immunogen sequence | AKKRFKDKSSEEAVREVHRLIEGKA |
| product line | Prestige Antibodies® Powered by Atlas Antibodies |
| Quality Level | 100 |
| shipped in | wet ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | immunoblotting: 0.04-0.4 μg/mL |
| immunofluorescence: 0.25-2 μg/mL | |
| immunohistochemistry: 1:1000-1:2500 | |
| UniProt accession no. | O94811  |
| Application: | All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies® protocols and other useful information. |
| Biochem/physiol Actions: | Tubulin polymerization promoting protein (TPPP) regulates oligodendrocyte differentiation. It interacts with tubulinand regulates microtubule bundle formation. Phosphorylation of TPPP at threonine or serine residue by mitogen-activated protein kinase 2 or by LIM kinase (LIMK) impactstubulin polymerization functionality. High expression of TPPP favors acetylation of microtubules. Deletion in the gene locus of TPPP may be implicated in the pathogenesis of cerebellar hypoplasia and facial dysmorphism in fetus. Mutations in the TPPP gene contributes to tumor progression in small cell lung cancer. TPPP localization with α-synuclein may help in the understanding neurodegeneration in Parkinson′s and Alzheimer′s diseases. TPPP promotes abnormal microtubule assemblies in alpha-synucleinopathies. |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| Features and Benefits: | Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section. Every Prestige Antibody is tested in the following ways: • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues. • Protein array of 364 human recombinant protein fragments. |
| General description: | Tubulin polymerization promoting protein (TPPP), also known as p25, is expressed in myelinating oligodendrocytes. TPPP is mapped to human chromosome 5p15.33. It has a p25 domain and is a disordered protein. |
| Immunogen: | tubulin polymerization promoting protein |
| Legal Information: | Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany |
| Other Notes: | Corresponding Antigen APREST80111 |
| Physical form: | Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |